Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Mitochondrial Membranes01:45

Mitochondrial Membranes

8.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
8.7K
Mitochondria01:37

Mitochondria

11.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A PARK9 iPSC-Derived Dopaminergic Neuron Model Enables Drug Screening Targeting Autophagy-Lysosome Pathway Dysfunction in Parkinson's Disease.

Journal of neurochemistry·2026
Same author

Pontine Hemorrhage Mimicking Bell's Palsy: Isolated Facial Nerve Palsy-A Case Report.

Case reports in neurological medicine·2026
Same author

Expanding the Spectrum of <i>BCAP31</i>-Associated Diseases: Early-Onset Parkinson Disease.

Neurology. Genetics·2026
Same author

A genome-wide association study identifies the GPM6A locus associated with age at onset in ALS.

Communications biology·2025
Same author

Chronic stress and the IL-10-mediated immunoregulatory loop in the pathogenesis of periodontitis.

Clinical science (London, England : 1979)·2025
Same author

Fully automated segmentation of substantia nigra toward longitudinal analysis of Parkinson's disease.

International journal of computer assisted radiology and surgery·2025

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Mitochondrial dysfunction in Parkinson's disease.

Nobutaka Hattori1,2, Shigeto Sato3,4

  • 1Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo, Tokyo, 113-8421, Japan. nhattori@juntendo.ac.jp.

Journal of Neural Transmission (Vienna, Austria : 1996)
|November 25, 2024
PubMed
Summary

Mitochondrial dysfunction is a key factor in Parkinson's disease (PD) cell death, impacting Complex I and alpha-ketoglutarate dehydrogenase. This dysfunction is observed in PD patients and linked to genes involved in mitochondrial health.

Keywords:
PARK2Autophagy-lysosome pathwayMitochondriaMitophagyParkinUbiquitin-proteasome pathway

More Related Videos

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.4K
Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

4.2K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

2.4K
Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

4.2K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • The precise cause of neuronal death in Parkinson's disease (PD) remains elusive.
  • MPTP-induced experimental parkinsonism research highlights mitochondrial respiratory failure as a primary cell death mechanism.
  • Toxic MPTP metabolites inhibit mitochondrial Complex I and alpha-ketoglutarate dehydrogenase.

Purpose of the Study:

  • To explore the role of mitochondrial dysfunction in Parkinson's disease pathogenesis.
  • To investigate the presence of mitochondrial deficits in PD patients and their potential systemic implications.
  • To examine genetic factors, including parkin (PRKN), PINK1, and CHCHD2, in relation to mitochondrial function in PD.

Main Methods:

  • Review of studies on MPTP-induced parkinsonism.
  • Analysis of mitochondrial Complex I and III activity in PD patients' tissues (brain, muscle, platelets).
  • Examination of alpha-synuclein accumulation in peripheral organs and mitochondrial DNA deletions in PD brains.

Main Results:

  • Mitochondrial dysfunction, particularly Complex I inhibition, is implicated in PD.
  • Deficiencies in mitochondrial complexes are found in various tissues of PD patients.
  • Evidence suggests PD may be a systemic disease, with genetic links to mitochondrial quality control pathways.

Conclusions:

  • Mitochondrial dysfunction is a significant contributor to cell death in Parkinson's disease.
  • Genetic factors like PRKN, PINK1, and CHCHD2 are involved in mitochondrial quality control relevant to PD.
  • Further research into mitochondrial mechanisms is crucial for understanding and treating PD.